[Sotalol prevents atrio-ventricular tachycardia but not atrial fibrillation with rapid ventricular response in a patient wiht WPW syndrome].
We present a case of 23-year-old male with the Marfan syndrome multiple accessory pathways and atrio-ventricular reentry ant tachycardia (AVRT) as well as atrial fibrillation (AF). Sotalol was partially effective for AVRT, however, it did not prevent AF, RF ablation cured all arrythmias. This case shows that sotalol can attenuate AVRT recurrences, however, it does not prevent rapid conduction via accessory pathways during AF.
Orczykowski
Michał
M
Instytut Kardiologii, Warszawa.
Szumowski
Lukasz
L
Szufladowicz
Ewa
E
Bodalski
Robert
R
Zakrzewska-Koperska
Joanna
J
Walczak
Franciszek
F
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017115:Catheter Ablation; D004562:Electrocardiography; D006801:Humans; D008297:Male; D008382:Marfan Syndrome / Q000188:drug therapy* / Q000601:surgery; D055502:Secondary Prevention; D013015:Sotalol / Q000627:therapeutic use*; D013610:Tachycardia / Q000517:prevention & control*; D017211:Treatment Failure
D000889:Anti-Arrhythmia Agents; D013015:Sotalol